Two Sigma Investments’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Two Sigma Investments’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,001	Closed	-$4K	–	2998
2022 Q2	$4K	Buy	+10,001	New	+$7K	﹤0.01%	2440

Other funds holding CRXT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Two Sigma Investments's CRXT Position: Q3 2022 in Review

Two Sigma Investments sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 10,001 shares — an estimated $4K sold.

Two Sigma Investments first reported a position in CRXT in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

Two Sigma Investments reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Two Sigma Investments sold 10,001 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $4K.
Two Sigma Investments first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Two Sigma Investments's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $4K in Q2 2022.
2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.